SCHEMBL6292867

SCHEMBL6292867

CCc1ccc(C(=O)O)c(O)c1CNC(=O)CCCCCNC(=O)OC(C)(C)C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.52
CA1 P00915 6/20 0.46
CA2 P00918 6/20 0.46
TDP1 Q9NUW8 1/20 0.41
DRD2 P14416 2/20 0.41
MAPT P10636 2/20 0.39
CA12 O43570 2/20 0.39
CA9 Q16790 2/20 0.39
KDM4E B2RXH2 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
GBA1 P04062 1/20 0.38
MEN1 O00255 1/20 0.38
GAA P10253 1/20 0.38
KMT2A Q03164 1/20 0.38
TLR8 Q9NR97 1/20 0.38
TLR7 Q9NYK1 1/20 0.38
TRPV1 Q8NER1 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6290071 0.83 CYP3A4 (0.56) CYP3A4CA1CA2TDP1DRD2
SCHEMBL6292887 0.79 CYP3A4 (0.53) CYP3A4CA1CA2TDP1DRD2
Trifluoroacetic Acid SCHEMBL6289465 0.77 HDAC3 (0.39) CYP3A4MEN1KMT2ATRPV1
SCHEMBL6292892 0.76 CYP3A4 (0.49) CYP3A4CA1CA2TDP1MAPT
SCHEMBL14102774 0.76 CYP3A4 (0.75) CYP3A4CA1CA2TDP1MAPT
SCHEMBL7207224 0.73 TDP1 (0.69) CYP3A4CA1CA2TDP1CA12
SCHEMBL9118035 0.72 CYP3A4 (0.60) CYP3A4CA1CA2TDP1DRD2
SCHEMBL7603561 0.72 CYP3A4 (0.52) CYP3A4CA1CA2TDP1DRD2
SCHEMBL6292866 0.71 DRD2 (0.41) CYP3A4CA1CA2TDP1DRD2
SCHEMBL23616304 0.71 TDP1 (0.61) CYP3A4CA1CA2TDP1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6870065-B2 Bifunctional boronic compound complexing reagents and complexes CAMBREX BIO SCIENCE ROCKLAND, INC. (US) 2005-03-22 US disclosed